Basel-based orthopedic firm, Medartis, has successfully completed the acquisition of an additional 18% stake in Geneva-based implant manufacturer, KeriMedical, for approximately CHF 18 million. This deal will raise Medartis’ stake to 47%, further cementing the company’s commitment to becoming a one-stop-shop for hand and wrist solutions, as well as increasing its presence in extremity joint […]
Search Results for: VISCHER
Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis had a pro-forma enterprise value of approximately USD 220m and a cash balance exceeding USD 117m prior to payment of […]
CODE41, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus and the opensource smart contract published by CMTA. VISCHER has advised CODE41 in the process. The team was led by partner Maxime Chollet (corporate/m&a, pictured) and included […]
Fangda Carbon New Material Co., an integrated carbon materials producer in in the People’s Republic of China with diversified product offerings, including graphite electrodes, carbon blocks, isostatic graphite and iron ore concentrates, sold 22m global depositary receipts (GDRs) at an offer price of USD 8.63 per GDR and listed on 15 March 2023 a total […]
The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to accelerate the commercialization of this early-stage company and to help it revolutionize cardiovascular education and training. Simulands plans to […]
Tobias F. Rohner has joined VISCHER as a partner on 1 February 2023 strengthening the tax team. As a partner in the Zurich office he is co-head of the tax team. With more than 20 years of experience as a tax lawyer, Rohner has excellent expertise in advising international and domestic companies, start-ups, fund and […]
As we have informed here, the Helsinn Group has closed a financing agreement with Oberland Capital Management. In this sense, VISCHER has advised Oberland Capital Management on its financing agreement with the Ticino based group. Oberland Capital is a private investment firm with assets under management in excess of USD 3 bn, focused exclusively on investing […]
The German company E3 Holding has acquired the clean-tek group from Felix Ritter. Clean-tek, based in Germany and Basel, is a leading manufacturer of modern cleanroom systems that uses technology for sensitive areas such as pharmaceutical production, medical technology, biotechnology or microelectronics. The company was founded in Renningen in 1986 by Albrecht Ritter, the father […]
As we have informed here, the AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys, a clinical-stage company based in Basel, Switzerland. The transaction marks the Fund’s first investment in Europe and is an important step toward building an international portfolio of companies that […]
Boris Räber joins Advokatur am Rosenberg from Walder Wyss, where he becomes a partner. He has many years of experience in national and international m&a transactions as well as private equity and venture capital transactions. As an experienced corporate lawyer, Boris Räber regularly advises start-ups and investors on financings (equity and debt), participation plans, exits […]
